Literature DB >> 26419375

IgG N-Glycosylation Galactose Incorporation Ratios for the Monitoring of Classical Galactosaemia.

Henning Stockmann1, Karen P Coss2, M Estela Rubio-Gozalbo3, Ina Knerr4, Maria Fitzgibbon5, Ashwini Maratha6, James Wilson7, Pauline Rudd1, Eileen P Treacy8,9,10.   

Abstract

Classical galactosaemia (OMIM #230400) is a rare disorder of carbohydrate metabolism caused by deficiency of the galactose-1-phosphate uridyltransferase enzyme (EC 2.7.7.12). The cause of the long-term complications, including neurological, cognitive and fertility problems in females, remains poorly understood. The relatively small number of patients with galactosaemia and the lack of validated biomarkers pose a substantial challenge for determining prognosis and monitoring disease progression and responses to new therapies. We report an improved method of automated robotic hydrophilic interaction ultra-performance liquid chromatography N-glycan analysis for the measurement of IgG N-glycan galactose incorporation ratios applied to the monitoring of adult patients with classical galactosaemia. We analysed 40 affected adult patients and 81 matched healthy controls. Significant differences were noted between the G0/G1 and G0/G2 incorporation ratios between galactosaemia patients and controls (p < 0.001 and <0.01, respectively). Our data indicate that the use of IgG N-glycosylation galactose incorporation analysis may be now applicable for monitoring patient dietary compliance, determining prognosis and the evaluation of potential new therapies.

Entities:  

Year:  2015        PMID: 26419375      PMCID: PMC4864864          DOI: 10.1007/8904_2015_490

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  26 in total

1.  High tolerance for oral galactose in classical galactosaemia: dietary implications.

Authors:  A M Bosch; H D Bakker; L J M de B Wenniger-Prick; R J A Wanders; F A Wijburg
Journal:  Arch Dis Child       Date:  2004-11       Impact factor: 3.791

2.  GALT deficiency causes UDP-hexose deficit in human galactosemic cells.

Authors:  K Lai; S D Langley; F W Khwaja; E W Schmitt; L J Elsas
Journal:  Glycobiology       Date:  2003-01-03       Impact factor: 4.313

3.  Biochemical monitoring of treatment for galactosaemia: biological variability in metabolite concentrations.

Authors:  A C Hutchesson; C Murdoch-Davis; A Green; M A Preece; J Allen; J B Holton; G Rylance
Journal:  J Inherit Metab Dis       Date:  1999-04       Impact factor: 4.982

4.  Long-term complications in Estonian galactosemia patients with a less strict lactose-free diet and metabolic control.

Authors:  K Krabbi; M-L Uudelepp; K Joost; R Zordania; K Õunap
Journal:  Mol Genet Metab       Date:  2011-04-02       Impact factor: 4.797

Review 5.  Glycosylated synaptomatrix regulation of trans-synaptic signaling.

Authors:  Neil Dani; Kendal Broadie
Journal:  Dev Neurobiol       Date:  2012-01       Impact factor: 3.964

6.  High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations.

Authors:  Maja Pucić; Ana Knezević; Jana Vidic; Barbara Adamczyk; Mislav Novokmet; Ozren Polasek; Olga Gornik; Sandra Supraha-Goreta; Mark R Wormald; Irma Redzić; Harry Campbell; Alan Wright; Nicholas D Hastie; James F Wilson; Igor Rudan; Manfred Wuhrer; Pauline M Rudd; Djuro Josić; Gordan Lauc
Journal:  Mol Cell Proteomics       Date:  2011-06-08       Impact factor: 5.911

Review 7.  Understanding human glycosylation disorders: biochemistry leads the charge.

Authors:  Hudson H Freeze
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

8.  Effects of temporary low-dose galactose supplements in children aged 5-12 y with classical galactosemia: a pilot study.

Authors:  Ina Knerr; Karen Patricia Coss; Jürgen Kratzsch; Ellen Crushell; Anne Clark; Peter Doran; Yoon Shin; Henning Stöckmann; Pauline Mary Rudd; Eileen Treacy
Journal:  Pediatr Res       Date:  2015-06-08       Impact factor: 3.756

9.  HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software.

Authors:  Louise Royle; Matthew P Campbell; Catherine M Radcliffe; Dawn M White; David J Harvey; Jodie L Abrahams; Yun-Gon Kim; George W Henry; Nancy A Shadick; Michael E Weinblatt; David M Lee; Pauline M Rudd; Raymond A Dwek
Journal:  Anal Biochem       Date:  2007-12-23       Impact factor: 3.365

10.  Involvement of endoplasmic reticulum stress in a novel Classic Galactosemia model.

Authors:  Tatiana I Slepak; Manshu Tang; Vladlen Z Slepak; Kent Lai
Journal:  Mol Genet Metab       Date:  2007-07-20       Impact factor: 4.797

View more
  4 in total

1.  Classical galactosaemia: novel insights in IgG N-glycosylation and N-glycan biosynthesis.

Authors:  Ashwini Maratha; Henning Stockmann; Karen P Coss; M Estela Rubio-Gozalbo; Ina Knerr; Maria Fitzgibbon; Terri P McVeigh; Patricia Foley; Catherine Moss; Hugh-Owen Colhoun; Britt van Erven; Kelly Stephens; Peter Doran; Pauline Rudd; Eileen Treacy
Journal:  Eur J Hum Genet       Date:  2016-01-06       Impact factor: 4.246

2.  Classical Galactosaemia and CDG, the N-Glycosylation Interface. A Review.

Authors:  Ashwini Maratha; Hugh-Owen Colhoun; Ina Knerr; Karen P Coss; Peter Doran; Eileen P Treacy
Journal:  JIMD Rep       Date:  2016-08-09

3.  Fertility in classical galactosaemia, a study of N-glycan, hormonal and inflammatory gene interactions.

Authors:  Hugh-Owen Colhoun; Estela M Rubio Gozalbo; Annet M Bosch; Ina Knerr; Charlotte Dawson; Jennifer Brady; Marie Galligan; Karolina Stepien; Roisin O'Flaherty; C Catherine Moss; P Peter Barker; Maria Fitzgibbon; Peter P Doran; Eileen P Treacy
Journal:  Orphanet J Rare Dis       Date:  2018-09-19       Impact factor: 4.123

4.  Abnormal N-glycan fucosylation, galactosylation, and sialylation of IgG in adults with classical galactosemia, influence of dietary galactose intake.

Authors:  Eileen P Treacy; Sebastian Vencken; Annet M Bosch; Matthias Gautschi; Estela Rubio-Gozalbo; Charlotte Dawson; Darragh Nerney; Hugh Owen Colhoun; Loai Shakerdi; Gregory M Pastores; Roisin O'Flaherty; Radka Saldova
Journal:  JIMD Rep       Date:  2021-07-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.